Xilio Therapeutics prices $40M pre-funded warrant offering; lead investor Coastlands Capital

Xilio Therapeutics, Inc.

Pre-funded warrants to purchase 74,780,300 common shares at $0.5349/warrant; exercise price $0.0001/share.
Gross proceeds ~$40M; net proceeds ~$37.1M after underwriting discounts and offering expenses.
Offering led by Coastlands Capital with participation from Gilead, OrbiMed, Perceptive Advisors.
Expected closing date February 13, 2026; net proceeds for product development and general corporate purposes.
Pre-funded warrants immediately exercisable; beneficial ownership capped at 4.99% (holder can elect up to 19.99%).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Xilio Therapeutics, Inc. entered into Underwriting Agreement with Leerink Partners LLC valued at approximately $37.1 million (effective 2026-02-11).

Action: entry
Agreement: underwriting
Counterparty: Leerink Partners LLC
Value: approximately $37.1 million
Effective: 2026-02-11

Exact text from the filing

On February 11, 2026, Xilio Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC, as representative of the underwriter named therein (the “Underwriter”), relating to an underwritten offering (the “Offering”) of pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 74,780,300 shares of common stock (the “Warrant Shares”) at a price to investors of $0.5349 per Pre-Funded Warrant.

View on SEC.gov

308 material agreements filed in the last 30 days. Browse all material agreements →

Xilio Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-048942

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.